Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06535022

DeliKet (Substudy of KetoNiFast Study ID 22-1398_1)

Postoperative delirium is a common problem of the critically ill patient and associated with an increased mortality. Intermittent fasting and ketogenesis have been shown to be beneficial for maintaining a circadian rhythm and initiating anti-inflammatory repair mechanisms which could potentially be neuroprotective. However, so far there is little data if cyclic enteral feeding with ketogenic nighttime fasting might be beneficial for reducing the rate of postoperative delirium. The study hypothesis is that equicaloric cyclic enteral feeding (12 hrs) during daytime with ketogenic fasting and exogenous ketone supplementation at nighttime compared to continuous standard enteral nutrition (24 hours) decreases the incidence of postoperative delirium in critically ill patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Postoperative delirium remains a common postoperative problem in critically ill patients with a prevalence of up to 20% and even up to 50% in the elderly population. But postoperative delirium has a negative impact on mortality as several studies were able to show in the past. Therefore, aiming for a reduction of postoperative delirium has an important impact on patients' outcome. One helpful tool for avoiding postoperative delirium is maintaining a circadian pattern. Enteral feeding may play an important role here. Healthy humans have a circadian feeding pattern with nighttime fasting. There is increasing evidence that a circadian rhythm of feeding (cyclic feeding) could be beneficial for critical ill patients. Cyclic feeding and fasting are assumed to have positive effects on the gut microbiome resulting in optimization of host responses to gastrointestinal pathogens. Another positive effect of cyclic feeding potentially results from activation of a "fasting response", inducing repair pathways such as ketogenesis, mitochondrial biogenesis, anti-inflammatory pathways, antioxidant defenses and autophagy processes. The activation of these repair pathways could diminish cellular stress and promote cellular recovery in critical ill patients. This could have a positive effect on postoperative delirium. A randomized controlled trial by van Dyck et al. could show that fasting-mimicking intervals of 12 hours are sufficient to generate a metabolic fasting response without risking a caloric deficit. This fasting response can be enhanced by additional supplementation of exogenous ketones. The study objective is that equicaloric cyclic enteral feeding (for 12 hours) during daytime with ketogenic fasting (for 12 hours) at nighttime (aiming for a ß-hydroxybutyrate blood concentrations ≥ 0.5mM by exogenous ketone supplementation) compared to continuous (for 24 hours) standard enteral nutrition as per patients' nutritional requirements decreases the incidence of postoperative delirium of critically ill patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years
  • Admission to an ICU
  • Start of enteral nutrition

Exclusion criteria

  • Severe liver insufficiency / liver disease (Child Pugh > B or 7-9 points)
  • Post total Pancreatectomy / Insulin-depending diabetes mellitus (IDDM)
  • Pregnancy / Lactation
  • Hemoglobin-concentration < 80g/l
  • Severe metabolic disorder / severe autoimmune disease
  • Refractory respiratory or metabolic acidosis
  • Disorder of mitochondrial transportation of fatty acids
  • Disorder of the oxidation of fatty acids
  • Disorder of gluconeogenesis, der ketone body production or ketone body degradation
  • Intermittent porphyria
  • Severe arrhythmia / cardiomyopathy
  • Contraindications against enteral nutrition
  • Missing informed consent

Treatment and study plan

Cyclic enteral daytime feeding with ketogenic nighttime fasting and exogenous ketone salt supplementation (ß-hydroxybutyrate)

Dietary Supplement

Nighttime fasting and ß-hydroxybutyrate supplementation

Other names: cyclic nutrition with nighttime fasting and exogenous ß-hydroxybutyrate supplementation

Primary outcomes

  1. Confusion Assessment Method (CAM- ICU)

    Time frame: Day 1-14 after randomization or until ICU discharge

    CAM ICU score (lowest score 0, highest score 7)

    • Cognitive function (MoCA- and MMST- Score) day 1, 7, 14 / ICU discharge
  2. • Montreal Cognitive Assessment (MoCA- Score)

    Time frame: Day 1-14 after randomization or until ICU- discharge

    • Cognitive function (MoCA- Score) (lowest Score 0, highest Score 30)
  3. MMSE (Minimental State Examination)

    Time frame: Day 1-14 after randomization or until ICU discharge

    MMSE Score (lowest Score 0, highest Score 30)

Secondary outcomes

  1. Duration of ventilation

    Time frame: From day of randomization until ICU discharge up to 1 month

    Length of invasive and noninvasive ventilation

  2. Length of ICU- and Hospital stay

    Time frame: From day of randomization until hospital discharge up to 6 months

    Length of ICU- and Hospital stay

  3. 30-day mortality

    Time frame: From day of randomization up until 30 days

    Mortality at day 30 after ICU admission

Study contacts

Contact information is provided by the study sponsor or research team.

Fabian Dusse, PD, MD

CONTACT

[email protected]

+49221478 ext. 40806

Sandra E Stoll, MD, assProf.

CONTACT

[email protected]

+49221478 ext. 82054

Sponsors and collaborators

Lead sponsor

University Hospital of Cologne

Other

Registry information

Official study title

Impact of Cyclic, Daytime Enteral Nutrition and Ketogenic Nighttime Fasting on the Incidence of Postoperative Delirium in Critically Ill Patients

Acronym: DeliKet

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Aug 2, 2024
Registry last updated
Aug 6, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.